MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Carolina BioOncology Institute
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

The Lake Norman Chamber of Commerce Recognizes Huntersville Physician Dr. John Powderly - The Lake Norman Chamber of Commerce recognizes Huntersville Physician Dr. John Powderly for his Commitment and Dedication to the Lake Norman Region - CarolinaBioOncology.org
The Lake Norman Chamber of Commerce Recognizes Huntersville Physician Dr. John Powderly

 

NewswireToday - /newswire/ - Cornelius, NC, United States, 2019/01/25 - The Lake Norman Chamber of Commerce recognizes Huntersville Physician Dr. John Powderly for his Commitment and Dedication to the Lake Norman Region - CarolinaBioOncology.org.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

On January 18, 2019, the Lake Norman Chamber of Commerce presented the John R. Cherry Community Award to Dr. John Powderly. This award is named in honor of John R. Cherry, the founder of the Chamber who has also been active in servant leadership for several decades. It is the highest award the Chamber presents to a member who has made a significant contribution to the community and region in civic service.

Dr. John Powderly of Huntersville operates the only independent Phase I Cancer Clinic plus human application lab in the United States. Over the last 13 years, Dr Powderly has provided access to cutting edge cancer treatment for over 3,000 patients through 80 clinical trials. His research on early phase immunotherapy research has led to over 100 publications.

Dr. Powderly had an inspiring message regarding his efforts in cancer treatment and research.

Speaking to the Chamber, he said “I founded Carolina BioOncology Institute in Huntersville in 2005 and have been a proud citizen of the Lake Norman region for many years. My goal was and remains to provide cancer patients access to the latest immunotherapy trials in a warm and caring environment. We are the only independent Phase I cancer research clinic in the US and work with multiple leading biotech partners to develop equipment and processes for the future. I am honored to be recognized with the John R. Cherry community service award. Patients inspire me, and it is my continuing mission to provide rapid access to treatment, without bureaucracy and administrative delays.”

About Carolina BioOncology Institute (CBOI)

Carolina BioOncology Institute (carolinabiooncology.org) was founded by Dr. John Powderly in 2005. With a mission to provide the highest level of comprehensive and quality medical care, the clinic focuses on Phase I clinical trials for immunotherapy-based cancer treatments. CBOI also houses a Human Applications Laboratory, BioCytics, whose goal is to bring personalized cellular immunotherapy cancer medicine to the market.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Carolina BioOncology Institute

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


The Lake Norman Chamber of Commerce Recognizes Huntersville Physician Dr. John Powderly

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Steve Bradley - CarolinaBioOncology.org 
980-441-1033 bizdev[.]carolinabiooncology.org
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Carolina BioOncology Institute securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Carolina BioOncology Institute / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ipsen Showcases Commitment to Patient-centric Advances in Oncology with Record Number of Abstracts to be Presented At ESMO 2020 Virtual Congress
Global Phase 3 Clinical Study of Pridopidine in Huntington’s Disease Announced
Ipsen to Present New Insights At ASBMR for Potential Treatment of Ultra-rare Disease Fibrodysplasia Ossificans Progressiva (FOP)
Ipsen to Present Results from MOVE, the First Global Phase III Trial in Fibrodysplasia Ossificans Progressiva (FOP) At ASBMR 2020 Annual Meeting
DSM Ignites New Strategic Initiative to Transform Global Animal Nutrition and Health
Jamjoom Pharmaceuticals Earns Acclaim from Frost & Sullivan for its Dominance in the KSA Pharma Market
DSM and Avril Complete Creation of Joint Venture to Develop Plant-based Protein
Ipsen Joins Clinical Collaboration to Evaluate Cabozantinib (CABOMETYX®) Plus Atezolizumab in Metastatic Non-small Cell Lung Cancer
Stevanato Group, SCHOTT, and Gerresheimer Confirm the Readiness to Support Future Covid-19 Vaccine with Pharmaceutical Containers
Ipsen Receives FDA Fast Track Designation for Liposomal Irinotecan (ONIVYDE®) as A First-line Combination Treatment for Metastatic Pancreatic Cancer
Ipsen Demonstrates Continued Commitment to Rare Diseases with Eight Abstracts Accepted At ENDO 2020 Published in the Journal of the Endocrine Society
Waters Corporation Earns New Product Innovation Award with First SmartMS-enabled Biopharmaceutical Solution
DSM Boosts Maternal and Infant Nutrition Portfolio with New Plant-based High Potency DHA Oil
Ipsen Enters into an Option Agreement with IRICoR and Université de Montréal for A Discovery-stage Oncology Program
Ipsen Announces Positive Topline Results from Pivotal Phase III CheckMate -9ER Trial Evaluating CABOMETYX®

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Huntington Study Group Ltd





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)